PIA
UTHR icon

Piedmont Investment Advisors’s United Therapeutics UTHR Stock Holding History

Piedmont Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,359
Closed -$319K – 670
2020
Q1 		$319K Hold
3,359
– – 0.01% 586
2019
Q4 		$296K Sell
3,359
-552
-14% -$48.6K 0.01% 763
2019
Q3 		$312K Sell
3,911
-311
-7% -$25K 0.01% 723
2019
Q2 		$330K Buy
+4,222
New +$395K 0.01% 730
2018
Q3 		– Sell
-8,330
Closed -$943K – 2223
2018
Q2 		$943K Sell
8,330
-1
-0% -$110 0.05% 315
2018
Q1 		$936K Buy
+8,331
New +$1.06M 0.03% 317
2017
Q2 		– Sell
-4,100
Closed -$555K – 786
2017
Q1 		$555K Hold
4,100
– – 0.01% 353
2016
Q4 		$588K Buy
4,100
+2,400
+141% +$306K 0.01% 301
2016
Q3 		$201K Buy
+1,700
New +$204K ﹤0.01% 367
2015
Q4 		– Sell
-11
Closed -$1.44K – 425
2015
Q3 		$1.44K Hold
11
– – ﹤0.01% 371
2015
Q2 		$1.91K Hold
11
– – ﹤0.01% 350
2015
Q1 		$1.9K Hold
11
– – ﹤0.01% 269
2014
Q4 		$1.42K Hold
11
– – ﹤0.01% 292
2014
Q3 		$1.42K Sell
11
-15
-58% -$1.55K ﹤0.01% 284
2014
Q2 		$2.3K Hold
26
– – ﹤0.01% 276
2014
Q1 		$2.44K Sell
26
-21
-45% -$2.15K ﹤0.01% 267
2013
Q4 		$5.31K Buy
47
+10
+27% +$902 ﹤0.01% 201
2013
Q3 		$2.92K Sell
37
-37,989
-100% -$2.78M ﹤0.01% 223
2013
Q2 		$2.5M Buy
+38,026
New +$2.45M 0.11% 102

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Piedmont Investment Advisors's UTHR Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of United Therapeutics (UTHR) in Q2 2020, closing a stake of 3,359 shares — an estimated $319K sold.

Piedmont Investment Advisors first reported a position in UTHR in Q2 2013 and held it in 19 quarters. The position peaked at $2.5M in Q2 2013. 349 funds tracked by Wall St. Rank hold UTHR as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining United Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 3,359 United Therapeutics shares in Q2 2020, an estimated $319K.
  • Piedmont Investment Advisors first reported a position in United Therapeutics in Q2 2013 and held it in 19 quarters.
  • Piedmont Investment Advisors's United Therapeutics position peaked at $2.5M in Q2 2013.
  • 349 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.